Home
Storia in 7 fonti
Eli Lilly: Erste klinische Daten zur Abnehmpille Orforglipron bekannt
Eli Lilly präsentiert erste Ergebnisse zur Abnehmpille Orforglipron. In einer Phase-III-Studie zeigten sich signifikante Gewichtsverluste.
- ·
wired.com
Eli Lilly’s Obesity Pill Shows Promising Weight Loss in New Results
In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 percent of their body weight.
- ·
cnbc.com
Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop
Eli Lilly's pill, orforglipron, is one step closer to becoming the first new, needle-free alternative in the booming market for weight loss and diabetes drugs.
